Blog
See below to check out the latest articles
- Buzz
- 4 March 2025
Answering questions and settling confusion around medical cannabis cards
As access to medical cannabis continues to expand, patients have more choices than ever before when...
- Buzz
- 3 March 2025
Prescription Not Prosecution: Medicinal Cannabis Charity, CannCare, Primed To Fight For Patients’ Rights
As the number of medicinal cannabis patients continues to rise here in Britain and internationally,...
- Buzz
- 3 March 2025
Medical marijuana boom for Australian exporters
David Henn, the founder of Germany’s biggest medicinal cannabis importer, says he cannot get enough...
- Buzz
- 3 March 2025
The Truth About Treating Health Problems With Cannabis
States around the U.S. have legalized cannabis, and there has been a significant increase in the...
- Buzz
- 28 February 2025
Village Farms International Expands Medical Cannabis Distribution to New Zealand
VANCOUVER, British Columbia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc....
- Buzz
- 28 February 2025
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
Stifel initiated coverage on Compass Pathways plc, saying, “The Time Is Now for Psychedelics....
- Buzz
- 27 February 2025
New Study Suggests Medical Cannabis Highly Cost-Effective Treatment for PTSD
Medical cannabis is a highly cost-effective treatment for individuals with moderate post-traumatic...
- Buzz
- 27 February 2025
UW study is looking at marijuana use in pregnancy
What, if any, are the impacts on infants if a pregnant person regularly uses marijuana during...
- Buzz
- 26 February 2025
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Enveric Biosciences has secured its first U.S. patent for the EVM401 Series, a novel collection of...
- Buzz
- 25 February 2025
Nearly Half of Canadian Cannabis Contains Just 80% of Advertised THC Levels
Canada’s pioneering Cannabis Data Gathering Program has published the results of a new study...
Subscribe Here!
Drive people to your products and services
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.